HALO logo
halo search icon
Longeveron Inc. Class A

US$0.71

Price Change Indicator
0.033 (4.93%)
Longeveron Inc. Class A
LGVN · NAS

Longeveron Inc. Class A

Start Trading LGVN for Free

US$0.71

Price Arrow0.033 (4.93%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Longeveron Inc. Class A Overview

LGVN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About LGVN

icon

Website

Longeveron Inc. Class A

icon

Telephone

1.844.470.2550

icon

Address

Suite 520, 1951 NW 7th Avenue, Life Science & Technology Park, Miami, FL 33136

Description

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

LGVN Price Chart

Key Stats

Market Cap

US$14.67M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.47 - 1.8

Trade Value (12mth)

US$409,430.00

1 week

0.42%

1 month

-33.99%

YTD

13.54%

1 year

-49.38%

All time high

450.00

Key Fundamentals

EPS 3 yr Growth

-85.60%

EBITDA Margin

NaN%

Operating Cashflow

-$19m

Free Cash Flow Return

-130.60%

ROIC

-159.00%

Interest Coverage

0.00

Quick Ratio

1.30

Other Data

Shares Outstanding (Fully Diluted)

25m

HALO Sector

Healthcare

Next Company Report Date

05-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LGVN Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

LGVN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-10.22-2.62-1.29locklocklock
EPS (Fully Diluted)
 $locklocklocklock-10.22-2.62-1.29locklocklock
Growth
 %locklocklocklock-13.874.450.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Longeveron Inc. Class A (LGVN:NAS)?
Halo FAQ
The current share price of Longeveron Inc. Class A (LGVN:NAS) is USD$0.71.
What is the 52-week high share price for Longeveron Inc. Class A (LGVN:NAS)?
Halo FAQ
The 52-week high share price for Longeveron Inc. Class A (LGVN:NAS) is USD$1.80.
What is the 52-week low share price for Longeveron Inc. Class A (LGVN:NAS)?
Halo FAQ
The 52-week low share price for Longeveron Inc. Class A (LGVN:NAS) is USD$0.47.
What is the dividend yield for Longeveron Inc. Class A (LGVN:NAS)?
Halo FAQ
Longeveron Inc. Class A (LGVN:NAS) does not pay a dividend.
What was Longeveron Inc. Class A (LGVN:NAS) last dividend payment?
Halo FAQ
Longeveron Inc. Class A (LGVN:NAS) does not pay a dividend.
What is the franking level for Longeveron Inc. Class A (LGVN:NAS)?
Halo FAQ
Longeveron Inc. Class A (LGVN:NAS) has a franking level of 0.00%.
In which sector is Longeveron Inc. Class A (LGVN:NAS) classified?
Halo FAQ
Longeveron Inc. Class A (LGVN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial